With U.S. now in hand, BioNTech CEO looks for more vaccine production

The chief executive of Germany's BioNTech SE said the biggest challenge facing it and partner Pfizer Inc now that their COVID-19 vaccine is authorized for use in the United States will be to scale up manufacturing to meet huge demand. "We need to solve the manufacturing challenge," Ugur Sahin told Reuters in an interview. The U.S. Food and Drug Administration authorized the vaccine for emergency use on Friday, after Britain became the first country to begin deploying the shot outside of clinical trials earlier in the week.

Motor Racing Legends continues expansion plans for 2021

Motor Racing Legends has further extended its 2021 plans by adding a second pre '66 Three-Hour race to its most ambitious UK race schedule to date

Light tank prototypes arrive at Fort Bragg for soldier evaluation

Mobile Protected Firepower prototypes will be put through the paces with the 82nd Airborne at Fort Bragg, North Carolina, at the start of the new year.

‘House Of the Dragon’: Olivia Cooke, Matt Smith & Emma D’Arcy To Star In HBO’s ‘Game of Thrones’ Prequel

Chadwick Boseman’s T’Challa Won’t Be Recast in ‘Black Panther 2’

Broadcom Inc. (AVGO) Q4 Earnings and Revenues Beat Estimates

Broadcom Inc. (AVGO) delivered earnings and revenue surprises of 1.44% and 0.77%, respectively, for the quarter ended October 2020. Do the numbers hold clues to what lies ahead for the stock?

Titans without 2 cornerbacks, Tart's suspension upheld